Azithromycin Combination Therapy for the Treatment of Severe Malaria

NCT01374126 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Falciparum Malaria

Interventions

DRUG: Artesunate
DRUG: Azithromycin + Artesunate

Sponsor

Medical University of Vienna

Collaborators

[object Object]